This includes considerations such as the expression levels of LAT1 in different types of cancer cells, the affinity of boron carriers for LAT1, the stability of the boron carriers in vivo, and the potential effects of local hypoxia on boron uptake. The gene discussed is SLC7A5; the disease is cancer.